Alta Partners — 2016 Investments
2 investments dated 2016 · listed companies and verified rows first · show all
Prolacta Bioscience manufactures 100% human milk-based nutritional products and fortifiers for premature and critically ill infants in hospital neonatal intensive care units.
BiotechHealthtechMedical DevicesCity Of Industry, US
Scott Elster(Executive Officer, Director)John M. Shields(Executive Officer)
BoardFrank Foster(Director)Martin Sutter(Director)David Brailer(Director)
Board seatDan Janney· per SEC Form D
Co-investorsAisling CapitalEssex Woodlands Healthcare PartnersFrontier Venture CapitalPROOF
South San Francisco biotech engineering commensal gut bacteria into controllable live therapeutics for chronic diseases.
Daly City, US
Weston Whitaker(Executive Officer, Director, Promoter)William DeLoache(Director)Samuel Smits(Director)
BoardElizabeth Stanley(Director)
Co-investorsCerity Partners Ventures5AM VenturesDCVC Bio
Rows marked “SEC filing” are inferred from directors named on the company's SEC Form D — public regulatory data, not a portfolio list published by the firm.